![Wendy Young](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 501 194 $ in data 31/08/2026
Wendy B. Young is currently an Independent Director at Rapport Therapeutics, Inc. since 2024, Adial Pharmaceuticals, Inc. since 2026, Terray Therapeutics, Inc., and Think Bioscience, Inc. Former positions include Chief Executive Officer at Stealth Co. from 2021 to 2023, Senior Vice President-Drug Discovery at Genentech, Inc. from 2018 to 2021, and Executive Partner at MPM BioImpact LLC.
Education includes undergraduate and graduate degrees from Wake Forest University and a doctorate from Princeton University conferred in 1993.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 6.000 ( 0,01% ) | 292 020 $ | 31/08/2026 | |
| 17/09/2026 | 36.378 ( 1,39% ) | 209 174 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/11/2024 |
| ADIAL PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 11/06/2026 |
Terray Therapeutics, Inc.
 Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for human diseases using spatially encoded screening optimization platform | Direttore/Membro del Consiglio | - |
Think Bioscience, Inc.
 Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Stealth Co.
 Stealth Co. Miscellaneous Commercial ServicesCommercial Services Operates as a sustainable personal care company intended to reduce environmental impact | Amministratore Delegato | 02/06/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 02/09/2021 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Adial Pharmaceuticals, Inc.
 Adial Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medications to treat addiction and related disorders | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terray Therapeutics, Inc.
Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for human diseases using spatially encoded screening optimization platform | Commercial Services |
Stealth Co.
Stealth Co. Miscellaneous Commercial ServicesCommercial Services Operates as a sustainable personal care company intended to reduce environmental impact | Commercial Services |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
